Publications by authors named "Delores Lindh"

Claim this Profile
A
An anti-MUC1 antibody-calicheamicin conjugate for treatment of solid tumors. Choice of linker and overcoming drug resistance.
Philip R Hamann, Lois M Hinman, Carl F Beyer, Lee M Greenberger, Clara Lin, Delores Lindh

Bioconjug Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A calicheamicin conjugate with a fully humanized anti-MUC1 antibody shows potent antitumor effects in breast and ovarian tumor xenografts.
Philip R Hamann, Lois M Hinman, Carl F Beyer, Delores Lindh, Janis Upeslacis

Bioconjug Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker.
Philip R Hamann, Lois M Hinman, Carl F Beyer, Delores Lindh, Janis Upeslacis

Bioconjug Chem· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.
Philip R Hamann, Lois M Hinman, Irwin Hollander, Carl F Beyer, Delores Lindh

Bioconjug Chem· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis